Sarepta Therapeutics (SRPT) had the highest return on March 25 by a mid-cap US stock, returning 20.3%.

ASSET	DATE	% RETURN
Sarepta Therapeutics (SRPT)	3/25/2026	20.29%
Corcept Therapeutics (CORT)	3/25/2026	18.51%
Firefly Aerospace Inc Common Stock (FLY)	3/25/2026	11.77%
Planet Labs PBC (PL)	3/25/2026	9.17%
Iridium Communications (IRDM)	3/25/2026	9.04%
Oruka Therapeutics (ORKA)	3/25/2026	9.03%
Almonty Industries Inc Common Shares (ALM)	3/25/2026	9.01%
Pattern Group Inc Series A Common Stock (PTRN)	3/25/2026	7.68%
Erasca (ERAS)	3/25/2026	7.32%
Acadia Healthcare (ACHC)	3/25/2026	7.14%
Tango Therapeutics (TNGX)	3/25/2026	6.53%
Celcuity LLC (CELC)	3/25/2026	6.43%
Spyre Therapeutics (SYRE)	3/25/2026	6.41%
Strive (ASST)	3/25/2026	6.27%
Arrowhead Pharmaceuticals (ARWR)	3/25/2026	6.08%
Talos Energy (TALO)	3/25/2026	5.99%
Parsons (PSN)	3/25/2026	5.9%
Axcelis Technologies (ACLS)	3/25/2026	5.86%
Comstock Resources (CRK)	3/25/2026	5.76%
Liberty Energy (LBRT)	3/25/2026	5.65%
Scholar Rock (SRRK)	3/25/2026	5.58%
SM Energy (SM)	3/25/2026	5.35%
Enliven Therapeutics (ELVN)	3/25/2026	5.26%
Praxis Precision Medicines (PRAX)	3/25/2026	5.09%
Brookfield Business (BBUC)	3/25/2026	5%

Mid-cap stocks are treated as having a market cap between $2B and $10B.